Uğur Özdemir1, Ebru Ortaç Ersoy2, Recep Civan Yüksel3, Erhan Kaya4, Gülbin Aygencel1, Melda Türkoğlu1, Arzu Topeli2, Muhammet Güven3, Murat Sungur3, Neriman Defne Altintaş4. 1. Division of Intensive Care Medicine, Department of Internal Medicine, Gazi University School of Medicine, Ankara, Turkey 2. Division of Intensive Care Medicine, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey 3. Division of Intensive Care Medicine, Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey 4. Division of Intensive Care Medicine, Department of Internal Medicine, Ankara University School of Medicine, Ankara, Turkey
Abstract
Background/aim: There is a need for a scoring system for predicting ICU prognosis of patients with ANCA-associated vasculitis (AAV), but there are limited data on it in the literature. Therefore, we aimed to determine the scores that can estimate the prognosis of patients with AAV during intensive care follow up. Materials and methods: All adult patients admitted to the medical ICUs of 4 reference university hospitals in Turkey due to AAV activation and/or disease/treatment complications in the last 10 years were included in this study. Demographic data, treatments before ICU, the Birmingham Vasculitis Activity Score (BVAS) score at the time of vasculitis diagnosis, and BVAS, APACHE II, SOFA, and SAPS II scores at the ICU admission, treatments, procedures, and complications during ICU stay were recorded for all AAV patients. Results: Thirty-four patients were included in the study. The median age of the patients was 60 (42–70) years, and 64.7% were male. Twenty-five patients were diagnosed with Granulomatosis with polyangiitis, and 9 were diagnosed with Microscopic polyangiitis. The most common ICU admission causes were hemorrhage (85.3%) and sepsis/septic shock (67.6%). Twenty patients (58.8%) died in the ICU follow up. There were significant differences in APACHE II (P = 0.004) and SAPS II (P = 0.044) scores between survivors and nonsurvivors, while there were no significant differences in BVAS (during diagnosis P = 0.089 and ICU admission P = 0.539) and SOFA (P = 0.097) scores. APACHE II score was found to be an independent risk factor for ICU mortality (OR = 1.231, CI 95% = 1.011–1.498, P = 0.038) according to logistic regression analysis. An APACHE II score of greater than 20.5 predicted ICU mortality with 80% sensitivity and 70% specificity (AUC = 0.8, P = 0.004, Likelihood ratio = 2.6) according to the ROC curve analysis. Conclusion: APACHE II score can be used for the prediction of ICU mortality in AAV patients. This work is licensed under a Creative Commons Attribution 4.0 International License.
Background/aim: There is a need for a scoring system for predicting ICU prognosis of patients with ANCA-associated vasculitis (AAV), but there are limited data on it in the literature. Therefore, we aimed to determine the scores that can estimate the prognosis of patients with AAV during intensive care follow up. Materials and methods: All adult patients admitted to the medical ICUs of 4 reference university hospitals in Turkey due to AAV activation and/or disease/treatment complications in the last 10 years were included in this study. Demographic data, treatments before ICU, the Birmingham Vasculitis Activity Score (BVAS) score at the time of vasculitis diagnosis, and BVAS, APACHE II, SOFA, and SAPS II scores at the ICU admission, treatments, procedures, and complications during ICU stay were recorded for all AAVpatients. Results: Thirty-four patients were included in the study. The median age of the patients was 60 (42–70) years, and 64.7% were male. Twenty-five patients were diagnosed with Granulomatosis with polyangiitis, and 9 were diagnosed with Microscopic polyangiitis. The most common ICU admission causes were hemorrhage (85.3%) and sepsis/septic shock (67.6%). Twenty patients (58.8%) died in the ICU follow up. There were significant differences in APACHE II (P = 0.004) and SAPS II (P = 0.044) scores between survivors and nonsurvivors, while there were no significant differences in BVAS (during diagnosis P = 0.089 and ICU admission P = 0.539) and SOFA (P = 0.097) scores. APACHE II score was found to be an independent risk factor for ICU mortality (OR = 1.231, CI 95% = 1.011–1.498, P = 0.038) according to logistic regression analysis. An APACHE II score of greater than 20.5 predicted ICU mortality with 80% sensitivity and 70% specificity (AUC = 0.8, P = 0.004, Likelihood ratio = 2.6) according to the ROC curve analysis. Conclusion: APACHE II score can be used for the prediction of ICU mortality in AAVpatients. This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors: Ravi Suppiah; Chetan Mukhtyar; Oliver Flossmann; Federico Alberici; Bo Baslund; Rajbir Batra; Denise Brown; Julia Holle; Zdenka Hruskova; David R W Jayne; Andrew Judge; Mark A Little; Alessandra Palmisano; Coen Stegeman; Vladimir Tesar; Augusto Vaglio; Kerstin Westman; Raashid Luqmani Journal: Rheumatology (Oxford) Date: 2010-12-13 Impact factor: 7.580
Authors: Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott Journal: Ann Rheum Dis Date: 2006-08-10 Impact factor: 19.103
Authors: Julien Demiselle; Johann Auchabie; François Beloncle; Philippe Gatault; Steven Grangé; Damien Du Cheyron; Jean Dellamonica; Sonia Boyer; Dimitri Titeca Beauport; Lise Piquilloud; Julien Letheulle; Christophe Guitton; Nicolas Chudeau; Guillaume Geri; François Fourrier; René Robert; Emmanuel Guérot; Julie Boisramé-Helms; Pierre Galichon; Pierre-François Dequin; Alexandre Lautrette; Pierre-Edouard Bollaert; Ferhat Meziani; Loïc Guillevin; Nicolas Lerolle; Jean-François Augusto Journal: Ann Intensive Care Date: 2017-04-05 Impact factor: 6.925
Authors: Antoine Kimmoun; Elisabeth Baux; Vincent Das; Nicolas Terzi; Patrice Talec; Pierre Asfar; Stephan Ehrmann; Guillaume Geri; Steven Grange; Nadia Anguel; Alexandre Demoule; Anne Sophie Moreau; Elie Azoulay; Jean-Pierre Quenot; Julie Boisramé-Helms; Guillaume Louis; Romain Sonneville; Nicolas Girerd; Nicolas Ducrocq; Nelly Agrinier; Denis Wahl; Xavier Puéchal; Bruno Levy Journal: Crit Care Date: 2016-01-26 Impact factor: 9.097